The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Carboplatin and etoposide followed by once-daily thoracic radiotherapy in limited-disease small-cell lung cancer.
Ufuk Yılmaz
No relevant relationships to disclose
Ceyda Anar
No relevant relationships to disclose
Esra Korkmaz
No relevant relationships to disclose
Sena Yapicioglu
No relevant relationships to disclose
Ilker Karadogan
No relevant relationships to disclose
Serdar Ozkok
No relevant relationships to disclose